WHERE IT BEGINS

September 20, 1950.

Off the coast of San Francisco, California.

Camp Detrick sat outside Frederick, Maryland, about fifty miles northwest of Washington. Before the war it had been a small airfield. By 1943, the War Department had transformed it into the headquarters of a classified program most Americans had never heard of and were not meant to: the nation's biological weapons effort. Within two years, the site had grown to include laboratories, test chambers, and production facilities, staffed by scientists who received security clearances before they received their assignments.

The wartime work focused on offense. Weaponizing anthrax. Producing botulinum toxin at scale. Studying delivery systems that could spread pathogens across enemy territory. After 1945, the focus shifted. The Soviet Union was building its own biological weapons capability. Intelligence assessments circulating through the Pentagon in the late 1940s said so. American defense planners needed to answer a defensive question: if the Soviets launched a biological attack on a U.S. city, what would happen? How far would an agent spread? How many people would be exposed? How fast?

Laboratory models could not answer with confidence. A wind tunnel could demonstrate how aerosolized particles behaved in a controlled chamber. It could not reproduce a real city, where buildings funneled wind, hills redirected airflow, automobile traffic generated thermal currents, and Pacific fog rolled through a coastal gap at unpredictable intervals. The limitation was understood within the program. The gap between a laboratory simulation and an actual urban environment was too wide for modeling alone to close.

The Army's Special Operations Division at Camp Detrick took a direct approach. Release biological agents over American cities and measure what happened. The agents would be simulants: organisms classified as harmless to humans but identifiable in a laboratory. Sampling stations at ground level would capture data on how far the organisms traveled, how densely they settled, and what the projected human exposure would be if the agent were lethal. The data would be used to build vulnerability assessments for American cities.

The cities selected for testing would not be notified. The people living in them would not consent. The program would be classified.

San Francisco was chosen early in the planning. The city sat on the tip of a peninsula, with the Pacific Ocean to the west, the Golden Gate strait to the north, and the bay to the east. Prevailing winds came onshore from the ocean and pushed eastward through the city's dense grid of neighborhoods, climbing the hills and funneling through the streets. Fog moving through the Golden Gate would carry aerosolized particles the same way it carried moisture. The bay provided open water where a ship could operate without drawing attention from shore. The population was concentrated. The terrain was contained.

The organism selected for the primary test was Serratia marcescens. It had a property that made it valuable as a tracer: when cultured on nutrient plates, its colonies turned bright red. This meant that researchers could collect samples from across the city after a release, grow the cultures, and count the red colonies to build a precise map of where the bacteria had traveled and in what concentration. Military scientists at Camp Detrick had classified the organism as nonpathogenic. It had been used in smaller tests before without reported incident. No medical monitoring plan had been put in place for the experiment. The absence of reported harm was taken as sufficient evidence of safety.

Elon Musk’s One Stock Retirement Plan

Sometimes you come across an opportunity so explosive…

That it has the potential to turn a small stake…

Into a six figure and in some rare cases even a seven-figure nest egg…

Like it happened when I picked Nvidia in 2016.

It jumped high enough to turn $5,000 into an entire retirement nest egg of $1,895,000.

And while I can’t guarantee you’ll become a millionaire...

I think this little-known AI stock is one of those opportunities…

Which is why I call it “Elon Musk’s One Stock Retirement Plan.”

Now, if this idea of retiring with a single stock sounds crazy to you…

You should know that some of the best investors in the world believe that the idea of diversification is a little overrated.

Stanley Druckenmiller said…

“You don’t get rich by diversifying into 50 mediocre assets. You get rich by finding two or three asymmetric home runs.”

Or listen to legendary investor Peter Lynch. He said…

“I would own one stock if I can find one great stock.”

Even Warren Buffett said…

“Diversification is protection against ignorance. It makes little sense if you know what you are doing.”

In September 1950, a Navy vessel moved into position off the coast of San Francisco. Over a period of eight days, beginning September 20, the crew operated aerosol generators that released large quantities of Serratia marcescens into the air. The releases were timed to coincide with wind conditions that would push the bacterial cloud across the widest possible area of the city. At dozens of collection points throughout San Francisco, sampling devices captured what arrived.

San Francisco in September 1950 was a working port city. The waterfront still moved cargo daily. Streetcars carried commuters downtown. Families in the residential districts lived in rows of houses that ran block after block toward the ocean, and most left windows open to the mild coastal air. The bacterial cloud that passed over all of it was invisible and odorless. It settled on skin, on clothing, on produce at corner markets. It was inhaled with every outdoor breath and most indoor ones. No one noticed anything.

The classified results confirmed broad dispersal. Sampling data showed that Serratia marcescens had traveled across the city and settled over an area of many square miles. The Army's analysis concluded that virtually every resident of San Francisco had been exposed during the test period. The bacteria had reached neighborhoods miles from the release point. A follow-up assessment noted that if the simulant had been replaced with a lethal pathogen and delivered the same way, the casualty projections would have been severe. The data was compiled, stamped classified, and filed. The test was marked a success.

No one outside the classified chain of command was told what had been done. The vulnerability data circulated within the biological warfare division and through select channels at the Pentagon. An American city could be blanketed with a biological agent delivered from a single vessel offshore, and its population would have no warning, no detection capability, and no knowledge that anything had happened. That was the finding. The operation was closed and the files were sealed.

Within days of the spraying, physicians at a hospital in San Francisco noticed something that did not fit the normal pattern. A cluster of patients presented with severe urinary tract infections caused by Serratia marcescens. Individually, a Serratia infection in a hospital was not extraordinary. But multiple cases appearing in rapid succession was clinically striking. The timing drew immediate attention. Eleven patients were identified in the cluster. The hospital's medical staff documented the outbreak in a paper published in a medical journal in 1951, describing the organism, the unusual concentration of cases, and the difficulty of treatment. They had no explanation for the sudden spike.

One of the eleven was Edward Nevin. He was 75 years old. Nevin had been admitted to the hospital for a prior condition and was recovering when the Serratia marcescens infection took hold. The bacterium entered his urinary tract and spread to his bloodstream. He developed endocarditis, an infection of the heart's inner lining, difficult to treat under any circumstances and more so in 1950. His physicians did what they could. The infection did not respond. Over the following weeks, his condition deteriorated. Edward Nevin died in the fall of 1950.

His death was recorded at the hospital. The organism that killed him was documented in his medical file, as it would be for any unusual infection. No physician who treated him had reason to suspect the United States military. The test was classified. No public announcement had been issued. The Army had not contacted any hospital in San Francisco to monitor for health effects, because the official position was that there would be none.

The classified files at Camp Detrick contained data that could have connected the hospital outbreak to the September release. The timing aligned precisely. The organism was the same one the Army had sprayed. The geography placed the hospital within the dispersal zone. But those files were sealed. They would remain sealed for more than a quarter of a century.

HOW THE CASE ENDED

The testing program did not stop with San Francisco. Over the next two decades, the Army's Special Operations Division conducted dozens of similar open-air releases in cities and public spaces across the country. In one operation in 1966, researchers dropped lightbulbs filled with a bacterial simulant onto the tracks of the New York City subway and measured how the organisms spread through the tunnel system. Other tests were carried out at bus stations, airports, and along highways in multiple states. The total number of American civilians exposed over the life of the program is not precisely known, but it reached into the millions.

The San Francisco test stayed classified for 27 years.

In 1977, the Senate Subcommittee on Health and Scientific Research, chaired by Senator Edward Kennedy, held hearings that examined the military's open-air biological testing program. Declassified Army documents were entered into the public record for the first time, and witnesses testified about the scope and methods of the tests. The San Francisco operation was among the cases reviewed in detail. The hearings documented the organisms used, the cities targeted, the absence of informed consent, and the Army's own classified assessments of what a real attack could produce. The information had been inside government files for nearly three decades. Now it was in the Congressional Record.

After the hearings, the family of Edward Nevin learned what had happened. His grandson, also named Edward Nevin, reviewed the declassified records and connected the September 1950 test to his grandfather's fatal infection. The family filed suit against the United States government in federal court.

The case went to trial in San Francisco in 1981. The government argued that the Army had no reason to believe Serratia marcescens was dangerous, because the prevailing scientific consensus in 1950 classified the organism as harmless. The government also argued that a direct causal link between the military release and the specific infection that killed Edward Nevin could not be proven with certainty. Serratia marcescens occasionally appeared in hospital settings on its own. The organism's presence in a patient's bloodstream, the government contended, did not by itself prove it had come from a military aerosol released over the city weeks earlier.

The judge ruled for the government. The Nevin family received nothing.

No criminal charges were filed against any military official or civilian planner involved in the San Francisco test or the broader open-air testing program. No officer was disciplined. No agency was restructured.

The Army acknowledged that the tests had taken place. It maintained that the simulants used were believed to be safe at the time and that the program served a legitimate national defense purpose.

Serratia marcescens is now recognized as an opportunistic pathogen capable of causing pneumonia, sepsis, and endocarditis, particularly in hospitalized patients and those with weakened immune systems.

Edward Nevin's death certificate, filed in 1950, names the organism that killed him. It does not mention the United States Army.

You'll wish it was fiction.